[Skip to Content]
[Skip to Content Landing]
September 19, 2001

Skin Manifestations of Fabry Disease

Author Affiliations

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;286(11):1315. doi:10.1001/jama.286.11.1311

To the Editor: Dr Schiffmann and colleagues1 reported that intravenous administration of α-galactosidase A has a number of beneficial effects in patients with Fabry disease. However, it would be of interest to know the extent of the patients' cutaneous lesions2,3 and whether they were affected by treatment with α-galactosidase A.